Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.

Abstract

Previous in vitro studies using spontaneously clotting whole blood revealed thrombin formation and high fibrinopeptide A (FPA) concentrations measured during incubation time. This occurred in spite of normal concentrations of thrombin antagonists present in the blood of the healthy subjects examined. However, there are several reports showing that in vivo increased thrombin-antithrombin III-complex (TAT) concentrations and relatively low FPA concentrations may occur e.g. in patients with (pre)thrombotic disorders. These in vivo findings indicate more effective thrombin inhibition by antithrombin III, with almost no fibrin formation. To find an explanation for the differences observed in vitro and in vivo, we extended the in vitro studies by measuring concentrations of prothrombin fragment 1 + 2 (F1 + 2), TAT and FPA at several time points until 30 min. Our goal was to test whether thrombin at least initially is neutralized by antithrombin III, resulting in a lack of fibrin formation, either in the absence or in the presence of heparin (0.2 and 0.5 U/ml whole blood, respectively). In the absence of heparin a simultaneous increase in the concentrations of F1 + 2, TAT and FPA was observed. Thrombin was only partially neutralized by antithrombin III and large amounts of fibrin were formed. The addition of heparin virtually suppressed thrombin formation since the F1 + 2 concentration remained low. Moreover, the small amounts of thrombin formed were neutralized by antithrombin III to a greater extent than in the absence of heparin.(ABSTRACT TRUNCATED AT 250 WORDS)

• Authors: T Herren, P W Straub, A Haeberli
• Journal: Thrombosis and haemostasis (Thromb Haemost) Vol. 71 Issue 1 Pg. 49-53 (Jan 1994) ISSN: 0340-6245 [Print] Germany
• PMID: 8165646 (Publication Type: Journal Article)

Chemical References

• Peptide Fragments
• antithrombin III-protease complex
• prothrombin fragment 1.2
• Fibrinopeptide A
• Antithrombin III
• Prothrombin
• Heparin
• Peptide Hydrolases

Topics

• Adult
• Antithrombin III (analysis)
• Antithrombin III Deficiency
• Blood Coagulation (drug effects)
• Female
• Fibrinopeptide A (analysis)
• Heparin (pharmacology)
• Humans
• Male
• Peptide Fragments (analysis)
• Peptide Hydrolases (analysis)
• Prothrombin (analysis)